HYPRHealthcare · Medical Devices

HYPR Stock Forecast: Hyperfine, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$0.54
+3.42% on the day

The median 12-month analyst price target for Hyperfine, Inc. is $2. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 42 of 100 as at 21 Nov 2026 — in the lower half.

Market cap
$58.0M
Ticker Nerd rank
42/ 100
Median analyst target
$2.00
Analysts covering
4
Revenue$3.9M+44.8% y/y
Operating income−$8.5M
Net income−$9.3M
Free cash flow−$7.3M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−13.8%
1M
−30.0%
YTD
−44.6%
1Y
−47.1%
From 52W high
−71.0%
From 52W low
+3.4%
$0.52
$1.87
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Hyperfine, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
42/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
98
Revisions
77
Volatility
51
Quality
35
Accruals
30
Value
25
Momentum
20
Issuance
8

Growth (98): Sales and profits are climbing, and climbing faster than before.

Issuance (8): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

HYPR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HYPR, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.50$1.00$1.50$2.00$2.50Jan 26Apr 26Jul 26Oct 26HYPRHigh $2.50Median $2.00Low $1.40

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says4 analysts
4
Buy
0
Hold
0
Sell
$1.40
Low
$2.00
Median
$2.50
High
Recent analyst actionsNewest first
DateFirmActionRatingTarget
18 Nov 2026B. Riley SecuritiesReiteratesBuy$1.60 → $1.40
27 Oct 2026Lucid Capital MarketsInitiatesBuy$2.00
22 Sept 2026BTIGReiteratesBuy$2.00
14 Sept 2026BTIGReiteratesBuy$2.00
10 Aug 2026B. Riley SecuritiesReiteratesBuy$2.00 → $1.60
29 Apr 2026BTIGInitiatesBuy$2.00
19 Mar 2026Lake StreetMaintainsBuy—
15 Aug 2025Wells FargoMaintainsEqual-Weight—
14 Aug 2025Lake StreetMaintainsBuy—
15 May 2025B. Riley SecuritiesMaintainsBuy—
14 May 2025Wells FargoMaintainsEqual-Weight—
24 Mar 2025Lake StreetInitiatesBuy—
20 Mar 2025B. Riley SecuritiesMaintainsBuy—
18 Mar 2025Wells FargoMaintainsEqual-Weight—
22 Mar 2024Wells FargoMaintainsEqual-Weight—
30 Nov 2023JefferiesInitiatesHold—
15 Aug 2023B. Riley SecuritiesMaintainsBuy—
22 Mar 2023B. Riley SecuritiesMaintainsBuy—
4 Oct 2022B. Riley SecuritiesInitiatesBuy—
11 Aug 2022Wells FargoDowngradeEqual-Weight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for HYPR.

Market Radar

This page is one stock. Monday covers all of them.

HYPR appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

HYPR vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Hyperfine, Inc. returned −47.1% against +6.9% for the S&P 500, dividends included.

HYPR vs S&P 500, last 12 monthsTotal return, rebased to 100
50100150200Jan 26Apr 26Jul 26Oct 26HYPRS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HYPR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
3.0×

Cheaper than 36% of US stocks

Price / book
1.8×

Cheaper than 47% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
50.7%

Higher than 63% of US stocks

Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−101.7%

Higher than 13% of US stocks

Return on assets
−40.2%

Higher than 10% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Hyperfine, Inc. has a market value of $58.0M and an enterprise value of $34.3M.

  • Revenue in the twelve months to 30 June 2026: $16.5M. The latest quarter grew 44.8% year on year.

  • Net income over the same four quarters: −$34.9M, a −210.8% net margin.

  • Diluted earnings per share, trailing twelve months: −$0.38.

  • Free cash flow in the twelve months to 30 June 2026: −$27.5M.

  • Shares outstanding: 106.0M.

  • Hyperfine, Inc. employs 102 people — $162K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 22 Nov 2026

Data provided by Twelve Data

Peers

HYPR and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
HYPRHyperfine, Inc.$58.0M42
LNSRLENSAR, Inc.$54.8M58
COCHEnvoy Medical, Inc.$51.9M57
OMOutset Medical, Inc.$51.4M52
SERASera Prognostics, Inc.$70.9M39
MBOTMicrobot Medical, Inc.$45.7M15
LUCDLucid Diagnostics, Inc.$75.7M36

Take a look at HYPR’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Hyperfine, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about HYPR

What is the HYPR stock price forecast for 2026-2027?

The median 12-month analyst price target for Hyperfine, Inc. is $2, with estimates ranging from $1.4 to $2.5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HYPR stock a buy right now?

Of the 4 analysts covering Hyperfine, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Hyperfine, Inc. 42 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HYPR?

As at 21 Nov 2026, Hyperfine, Inc. ranks 42 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (98 of 100).

Will HYPR stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts is $2, and Ticker Nerd's factor model ranks Hyperfine, Inc. 42 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HYPR stock forecast for 2030?

No analyst covering Hyperfine, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HYPR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1.4 to $2.5 over the next 12 months.

How has HYPR stock performed over the past year?

Hyperfine, Inc. returned -47.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Hyperfine, Inc. do?

Hyperfine, Inc. Class A Common Stock represents the equity of Hyperfine, Inc., a health technology and medical device company focused on portable magnetic resonance imaging. The company develops and commercializes the Swoop portable MR imaging system, which is designed to support brain imaging and clinical monitoring in settings where traditional MRI systems are less practical.

Company

About Hyperfine, Inc.

Hyperfine, Inc. Class A Common Stock represents the equity of Hyperfine, Inc., a health technology and medical device company focused on portable magnetic resonance imaging. The company develops and commercializes the Swoop portable MR imaging system, which is designed to support brain imaging and clinical monitoring in settings where traditional MRI systems are less practical. Hyperfine also provides related support, maintenance, and technical services tied to its imaging products. Its offerings serve hospitals, intensive care units, stroke centers, and other medical facilities that use portable neuroimaging to help broaden access to diagnostic imaging. Based in Guilford, Connecticut, Hyperfine operates in the medical specialties segment of the health technology market, where it combines imaging hardware, software, and service capabilities around ultra-low-field MRI applications.

CEO Ms. Maria Degois-Sainz · 102 employees · United States · https://www.hyperfinemri.com